Integra LifeSciences Holdings Corporation
NASDAQIntegra LifeSciences heads into its Q2 earnings today with a sharp divergence between defensive options positioning and a short interest that has been retreating for weeks. The most striking signal is in options. Traders have turned meaningfully more cautious into the print: the put/call ratio jumped to 0.35 on Tuesday, more than three standard deviations above its 20-day average…
Snapshot as of 6 Aug 2026
Integra LifeSciences heads into its Q2 earnings today with a sharp divergence between defensive options positioning and a short interest that has been retreating for weeks. The most striking signal is in options.…
IART heads into its August 4 earnings print with a notable divergence: short sellers have been quietly retreating for six weeks straight, yet the CFO just sold shares near the top of the recent range. The most…
Integra LifeSciences just delivered the kind of earnings beat that reminds shorts why crowded positions are dangerous — the stock jumped 24% in a single session, leaving 16% of its free float still short and the…
Integra LifeSciences heads into its Q1 2026 earnings call — confirmed for May 5 — with short sellers adding aggressively and the stock at a multi-year low of $10.08. Short interest is the dominant story here, and it is…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for IART — free to start on ORTEX.
Sign up for free →Open IART on ORTEX